1my7: Difference between revisions

New page: left|200px<br /><applet load="1my7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1my7, resolution 1.49Å" /> '''NF-kappaB p65 subuni...
 
No edit summary
Line 1: Line 1:
[[Image:1my7.gif|left|200px]]<br /><applet load="1my7" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1my7.gif|left|200px]]<br /><applet load="1my7" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1my7, resolution 1.49&Aring;" />
caption="1my7, resolution 1.49&Aring;" />
'''NF-kappaB p65 subunit dimerization domain homodimer N202R mutation'''<br />
'''NF-kappaB p65 subunit dimerization domain homodimer N202R mutation'''<br />


==Overview==
==Overview==
IkappaBalpha inhibits transcription factor NF-kappaB activity by specific, binding to NF-kappaB heterodimers composed of p65 and p50 subunits. It, binds with slightly lower affinity to p65 homodimers and with, significantly lower affinity to homodimers of p50. We have employed a, structure-based mutagenesis approach coupled with protein-protein, interaction assays to determine the source of this dimer selectivity, exhibited by IkappaBalpha. Mutation of amino acid residues in IkappaBalpha, that contact NF-kappaB only marginally affects complex binding affinity, indicating a lack of hot spots in NF-kappaB/IkappaBalpha complex, formation. Conversion of the weak binding NF-kappaB p50 homodimer into a, high affinity binding partner of IkappaBalpha requires transfer of both, the NLS polypeptide and amino acid residues Asn202 and Ser203 from the, NF-kappaB p65 subunit. Involvement of Asn202 and Ser203 in complex, formation is surprising as these amino acid residues occupy solvent, exposed positions at a distance of 20A from IkappaBalpha in the crystal, structures. However, the same amino acid residue positions have been, genetically isolated as determinants of binding specificity in a, homologous system in Drosophila. X-ray crystallographic and solvent, accessibility experiments suggest that these solvent-exposed amino acid, residues contribute to NF-kappaB/IkappaBalpha complex formation by, modulating the NF-kappaB p65 subunit NLS polypeptide.
IkappaBalpha inhibits transcription factor NF-kappaB activity by specific binding to NF-kappaB heterodimers composed of p65 and p50 subunits. It binds with slightly lower affinity to p65 homodimers and with significantly lower affinity to homodimers of p50. We have employed a structure-based mutagenesis approach coupled with protein-protein interaction assays to determine the source of this dimer selectivity exhibited by IkappaBalpha. Mutation of amino acid residues in IkappaBalpha that contact NF-kappaB only marginally affects complex binding affinity, indicating a lack of hot spots in NF-kappaB/IkappaBalpha complex formation. Conversion of the weak binding NF-kappaB p50 homodimer into a high affinity binding partner of IkappaBalpha requires transfer of both the NLS polypeptide and amino acid residues Asn202 and Ser203 from the NF-kappaB p65 subunit. Involvement of Asn202 and Ser203 in complex formation is surprising as these amino acid residues occupy solvent exposed positions at a distance of 20A from IkappaBalpha in the crystal structures. However, the same amino acid residue positions have been genetically isolated as determinants of binding specificity in a homologous system in Drosophila. X-ray crystallographic and solvent accessibility experiments suggest that these solvent-exposed amino acid residues contribute to NF-kappaB/IkappaBalpha complex formation by modulating the NF-kappaB p65 subunit NLS polypeptide.


==About this Structure==
==About this Structure==
1MY7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1MY7 OCA].  
1MY7 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1MY7 OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Ghosh, G.]]
[[Category: Ghosh, G.]]
[[Category: Huang, D.B.]]
[[Category: Huang, D B.]]
[[Category: Hughes, C.A.]]
[[Category: Hughes, C A.]]
[[Category: Huxford, T.]]
[[Category: Huxford, T.]]
[[Category: Komives, E.A.]]
[[Category: Komives, E A.]]
[[Category: Mishler, D.]]
[[Category: Mishler, D.]]
[[Category: Phelps, C.B.]]
[[Category: Phelps, C B.]]
[[Category: Reeves, R.]]
[[Category: Reeves, R.]]
[[Category: Sengchanthalangsy, L.L.]]
[[Category: Sengchanthalangsy, L L.]]
[[Category: activator]]
[[Category: activator]]
[[Category: beta-sandwich]]
[[Category: beta-sandwich]]
Line 32: Line 32:
[[Category: transcription regulation]]
[[Category: transcription regulation]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 21:48:22 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:00:16 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA